Aug 2026· Discover Oncology· Vol 17· 0 citations· 33 references
Abstract
Colorectal cancer (CRC) ranks among the most prevalent malignancies globally, yet exhibits limited responsiveness to immunotherapy. This therapeutic challenge stems primarily from incomplete understanding of immune microenvironment regulation in CRC. Although Eomesodermin (EOMES) has been implicated in tumor immune checkpoint gene expression, its specific interaction and regulatory mechanisms within the CRC immune microenvironment require systematic investigation. RNA-sequencing expression profiles and corresponding clinical information for 33 types of tumors were downloaded from the TCGA dataset for Pan-Cancer analysis of gene EOMES. Single cell sequencing data of CRC from TISCH was used for single-gene analysis of EOMES. The primary human CRC tissue samples were obtained for tissue multiplexed immunofluorescence staining. The isolated CD8+ T cells were cocultured with MC38 cells, following by real-time PCR detection, immunoblotting assay, and flow cytometry analysis. Pan-cancer analysis demonstrated that EOMES expression was significantly elevated in tumor tissues from 33 cancer types (including COAD/READ) compared to normal tissues (BRCA, DLBC, ESCA et al.). Further immune microenvironment correlation analysis showed that EOMES expression strongly correlates with immune microenvironment modulation, particularly in COAD. Importantly, elevated EOMES levels were identified in exhausted CD8⁺ T cells within CRC tissues (COAD/READ subtypes). Moreover, EOMES expression demonstrates significant linkage to immune/inflammatory regulatory pathways in CRC. High EOMES⁺CD8⁺ T cell infiltration occurs in microsatellite-stable (MSS) CRC but not in microsatellite instability-high (MSI-H) CRC. Most importantly, EOMES expression positively correlates with exhausted CD8⁺ T cells exclusively in MSS CRC. Further in vitro experiments demonstrated the strong link between EOMES upregulation and CD8+ T cell exhaustion, thereby impairing their cytotoxic function against CRC cells. EOMES critically participates in CRC immune microenvironment regulation, with its upregulation positively associated with exhausted CD8⁺ T cell infiltration. This association is most pronounced in MSS CRC, revealing a subtype-specific immunomodulatory mechanism.
Background The role of Filamin A (FLNA) in colorectal cancer (CRC), particularly within the stromal compartment, remains poorly defined. This study investigates its expression, function, and clinical relevance in CRC. Methods We integrated transcriptomic data from the GSE39582 training cohort and TCGA/GSE75316 validati...
Q. Yao, Ning-Bo Liu, Shi-Long Li et al.· Journal of Cancer· 0 citations
Tetratricopeptide repeat domain protein 39B (TTC39B) is a lipid metabolism–related gene recently implicated in cholesterol regulation. However, its clinical and biological relevance in human cancers remains undefined.
Based on multi-omics data from the Cancer Genome Atlas (TCGA) pan-cancer dataset represen...
Hui-Juan Yi, Yan Wang, Chen-Hao Zhao et al.· BMC Medical Genomics· 0 citations
INTRODUCTION
Our preliminary findings indicate that bioinformatic analysis of the Cancer Genome Atlas (TCGA) database reveals a significant upregulation of Mitotic-Spindle Organizing Protein 1 (MZT1) in Lung Adenocarcinoma (LUAD) cohorts compared to normal controls; however, the underlying molecular mechanisms remain e...
Zhao-Ting Hu, Yu-Xin Chen, Yi-Xin Chen et al.· Current Cancer Drug Targets· 0 citations
Breast cancer is the most common malignancy in women and a major cause of cancer-related deaths, yet effective biomarkers that predict progression and guide therapy remain limited. This study explored the role of Transcription Factor 19 (TCF19) in breast cancer using public multi-omics datasets and in vitro functional...
Shi-Wei Liu, Ya'nan Liu, Shi-Hang Yang et al.· Current Issues in Molecular...· 0 citations
These findings provide a comprehensive characterization of CTCs and CTACs in PC using a multiplex biomarker panel associated with calcium signaling and immune checkpoint pathways, highlighting the pronounced heterogeneity and potential clinical relevance of these circulating cell populations.
Chrysoula Tagari, Karolina Mangani, Michael Gogolides et al.· Frontiers in Cell and Develo...· 0 citations
Immune imbalance in tumor microenvironment is closely linked to GC progression. MDSCs primarily drive immune imbalance by suppressing the anti-tumor activity of CD8⁺T cells. Notably, no prior study has explored the combination of CD8⁺T cells and MDSCs to assess the clinical prognosis or immunotherapy response in...
Ming-Liang Wang, Ying Zhang, Xue-Bin Wang et al.· Molecular Medicine· 0 citations
We use cookies to run the site and, with your consent, for analytics and to show ads.
See our Cookie Policy.